Filing Flows › Comparisons › LFVN vs VTVT
Lifevantage vs vTv Therapeutics: LFVN and VTVT compared
Lifevantage is the larger company: $37.1M of revenue in its latest quarter (Q3 2026) against $36.8M for vTv Therapeutics (Q1 2026). vTv Therapeutics is more profitable, with an operating margin of 63.1% against -0.4%.
Where the money goes: LFVN and VTVT
Lifevantage (LFVN) · Q3 2026
Lifevantage, Q3 2026: revenue $37.1M (-22% year over year), operating margin -0.4%, net loss $196K, operating cash flow $533K. The chart follows the revenue to costs, profit and cash.
vTv Therapeutics (VTVT) · Q1 2026
vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.
| Lifevantage (LFVN) | vTv Therapeutics (VTVT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 2026 |
| Revenue | $37.1M | $36.8M |
| Revenue growth, Y/Y | -22% | — |
| Operating margin | -0.4% | 63.1% |
| Net earnings | −$196K | $24.1M |
| Net margin | -0.5% | 65.5% |
| Operating cash flow | $533K | $9.2M |
Where the revenue comes from
Lifevantage
- Protandim: $18.0M (48%)
- True Science Product Line: $7.6M (20%)
- Life Vantage Product Line: $4.8M (13%)
- AXIO Product Line: $2.9M (8%)
Questions
Which is bigger, Lifevantage or vTv Therapeutics?
Lifevantage is the larger company: $37.1M of revenue in its latest quarter (Q3 2026) against $36.8M for vTv Therapeutics (Q1 2026).
Is Lifevantage or vTv Therapeutics growing faster?
vTv Therapeutics is more profitable, with an operating margin of 63.1% against -0.4%.
More: Lifevantage earnings · how Lifevantage makes money · vTv Therapeutics earnings · how vTv Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed May 13, 2026). Fiscal quarters can end on different dates. Not investment advice.